The follicular non-Hodgkin's lymphomas - I. The possibility of cure

European Journal of Cancer

Volumn 32, Issue 3, 1996, Pages 470-479

  Denham, J W ^c   Denham, E ^c   Dear, K B ^a   Hudson, G V ^b  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b MIDDLESEX HOSPITAL   (United Kingdom)

^c NONE

Author keywords

Chemotherapy; Cured subsets; Follicular; Long term follow up; Nodular; Non Hodgkin's lymphoma; Radiotherapy

Indexed keywords

CHLORAMBUCIL;

ARTICLE; CLINICAL TRIAL; FOLLICULAR LYMPHOMA; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; NONHODGKIN LYMPHOMA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SURVIVAL;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHLORAMBUCIL; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHOMA, FOLLICULAR; MALE; NEOPLASM STAGING; PREDNISONE; RECURRENCE; RISK FACTORS; SURVIVAL ANALYSIS; VINCRISTINE;

EID: 0029985567     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/0959-8049(95)00607-9     Document Type: Article

References (61)

1. Luce JK, Gamble JF, Wilson HE, Monto RW, Isaaacs BL, Palmer RL. Combined cyclophosphamide, vincristine and prednisone therapy of malignant lymphoma. Cancer 1970, 28, 306-317.
2. Bagley CM, De Vita VT, Berard CW, Canellos GP. Advanced lymphosarcoma: intensive cyclical combination chemotherapy with cyclophosphamide, vincristine and prednisone. Ann Intern Med 1972, 76, 227-234.
3. KcKelvie EM, Gottlier JA, Wilson HE, et al. Hydroxydaunomycin (adriamycin) combination chemotherapy in malignant lymphoma. Cancer 1976, 38, 1484-1493.
4. Anderson T, Bender RA, Fisher RI, De Vita VT, Chabner BA, Berard CW. Combination chemotherapy in non-Hodgkin's lymphoma: results of long term follow up. Cancer Treat Rep 1977,. 61, 1057-1066.
5. De Vita VT, Serpick AA, Carbone PP. Combination chemotherapy in the treatment of advanced Hodgkin's disease. Ann Intern Med 1970, 73, 881-895.
6. Glastein E, Guernsey JM, Rosenberg SA, Kaplan HS. The value of laparotomy and splenectomy in the staging of Hodgkin's disease. Cancer 1969, 24, 709-718.
7. Hass AC, Brunk SF, Gulesserian HP, Givler RL. The value of exploratory laparotomy in malignant lymphoma. Radiology 1971, 101, 157-165.
8. Bartlett NL, Rizeq M, Dorfman RF, Halpern J, Horning SJ. Follicular large-cell lymphoma: intermediate or low grade? J Clin Oncol 1994, 12, 1349-1357.
9. Hanks GE, Terry LN, Bryan JA, Newsome JF. Contribution of diagnostic laparotomy to staging non-Hodgkin's lymphoma. Cancer 1972, 29, 41-43.
10. Goffinet DR, Castellino RA, Kim H, Dorfman RF, Fuks Z, Rosenberg SA. Staging laparotomy in unselected previously untreated patients with non-Hodgkin's lymphomas. Cancer 1973, 32, 672-686.
11. Ferguson DJ, Allen LW, Griem ML, Moran ME, Rappaport H, Ultmann JE. Surgical experience with staging laparotomy in 125 patients with lymphoma. Arch Intern Med 1973, 131, 356-361.
12. Veronesi V, Musemeci R, Pizzett F, Gennari L, Bonnadonna G. The value of staging laparotomy in non-Hodgkin's lymphomas (with emphasis on the histiocytic type). Cancer 1974, 33, 446-454.
13. Jelliffe AM. Diagnostic laparotomy in non-Hodgkin's lymphoma. Br J Cancer 1975, 31, 248-251.
14. Moran EM, Ultmann JE, Ferguson DJ, Hoffer PB, Ranniger K, Rappaport H. Staging laparotomy in non-Hodgkin's lymphoma. Br J Cancer 1975, 31, 228-236.
15. Lotz MJ, Chabner B, De Vita VT, Johnson RE, Berard CW. Pathologic staging of 100 consecutive untreated patients with non-Hodgkin's lymphoma. Cancer 1976, 37, 266-270.
16. Collins RD, Lukes RJ. Studies on the possible derivation of some malignant lymphomas from follicular centre cells. Am J Pathol 1971, 62, 63.
17. Lukes RJ, Collins RD. New observations on follicular lymphoma. Gann Monogr Cancer Res 1973, 15, 209-215.
18. Lennert K. Follicular lymphoma. A tumour of the germinal centres. Gann Monog Cancer Res 1973, 15, 217-231.
19. Bennett MH, Farrer-Brown G, Henry K. A classification of the non-Hodgkin's lymphomas. Presented at the workshop on classification of non-Hodgkin's lymphomas, University of Chicago. Clin Radiol 1973, 20, 339-343.
20. Jaffe ES, Shevach EM, Frank MM, Berard CW, Green I. Nodular lymphoma - evidence for origin from follicular B lymphocytes. N Engl J Med 1974, 290, 813-819.
21. Salmon SE, Seligmann M. B-cell neoplasia in man. Lancet 1974, ii, 1230-1233.
22. Jaffe ES, Shevach EM, Sussman EH. Membrane receptor sites for the identification of lymphoreticular cells in benign and malignant conditions. Br J Cancer 1975, 31, 107-120.
23. Seligmann M, Brouet JC, Preud'Homme JL. Immunologic classification of non-Hodgkin's lymphomas: current status. Cancer Treat Rep 1977, 61, 1179-1183.
24. Galton DAG, Catovsky D, Wiltshaw E. Clinical spectrum of lymphoproliferative disease. Cancer 1978, 42, 901-910.
25. Weissman IL, Warnke R, Butcher EC, Rouse R, Levy R. The lymphoid system: its normal architecture and the potential for understanding the system through the study of lymphoproliferative diseases. Hum Pathol 1978, 9, 25-45.
26. Warnke R, Levy R. Immunopathology of the follicular lymphomas - a model of 'B' lymphocyte homing. N Engl J Med 1978, 298, 481-486.
27. Schein PS, Chabner BA, Canellos GP, Young RC, De Vita VT. Non-Hodgkin's lymphomas: patterns of relapse from complete remission after combination chemotherapy. Cancer 1975, 35, 354-357.
28. De Vita VT, Canellos GP, Chabner BA, Schein PS, Hubbard SP, Young RC. Advanced diffuse histiocytic lymphoma a potentially curable disease. Lancet 1975, i, 248-250.
29. McKelvie EM, Moon TE. Curability of non-Hodgkin's lymphoma. Cancer Treat Rep 1977, 61, 1185-1190.
30. Young RC, Anderson T, Bender RA. Nodular mixed lymphoma (NML). Another potentially curable non-Hodgkin's lymphoma. Proc Am Soc Clin Oncol 1977, 18, 356.
31. Portlock CS, Glastein E. The non-Hodgkin's lymphomas: current concepts and management. Ann Rev Med 1978, 29, 81-91.
32. Rosenberg SA. Non-Hodgkin's lymphoma - selection of treatment on basis of histologic type. N Engl J Med 1979, 301, 924-928.
33. Ezdinli E, Costello WG, Fikri I, et al. Nodular mixed lymphocytic-histiocytic lymphoma. Response and survival. Cancer 1980, 45, 261-267.
34. Muggia FM, Davis HH, Rosencweig M. Current cooperative trials in the non-Hodgkin's lymphomas. Cancer Treat Rep 1977, 61, 1191-1197.
35. Nissen NI, Pajak T, Glidewell O, Blom H, Flaherty M, Hayes D. Overview of four clinical studies of chemotherapy for stage III and IV non-Hodgkin's lymphomas by the Cancer and Leukaemia Group B. Cancer Treat Rep 1977, 61, 1097-1107.
36. Cabanillas F, Smith T, Bodey GP, Gutterman JV, Freireich EJ. Nodular malignant lymphomas: factors affecting complete response rate and survival. Cancer 1979, 44, 1983-1989.
37. Dumont J, Asselain B, Weil M, et al. Evolution centaine des lymphomes nodulaire. Devenir de 85 malades traites entre 1968 et 1975. Nouv Presse Med 1981, 10, 2261-2265.
38. Rassiga A, Bartolucci A, Gams R, Durant J. Effect of chemotherapeutic regime on induction rate and survival in good risk non-Hodgkin's lymphoma. Proc Am Soc Clin Oncol 1981, C719.
39. Hayhoe FGH. Chemotherapy in the management of stage III/IV grade I non-Hodgkin's lymphomas. (Report No. 17). Clin Radiol 1981, 32, 547-552.
40. Horning SJ, Rosenberg SA. The natural history of initially untreated low-grade non-Hodgkin's lymphomas. N Engl J Med 1984, 311, 1471-1475.
41. Cheson PD, Wittes RE, Friedman MA. Low-grade non-Hodgkin's lymphomas revisited. Cancer Treat Rep 1986, 70, 1051-1054.
42. O'Brien M, Easterbrook P, Powell J, et al. The natural history of low-grade non-Hodgkin's lymphoma and the impact of a no initial treatment policy on survival. Q J Med 1991, 292, 651-660.
43. Paryani S, Hoppe RT, Cox R, Colby T, Rosenberg SA, Kaplan HS. Analysis of non-Hodgkin's lymphomas with nodular and favourable histologies, stages I and II. Cancer 1983, 52, 2300-2307.
44. Gospodarowicz MK, Bush RS, Brown TC, Chau T. Prognostic factors in nodular lymphomas: a multivariate analysis based on the Princess Margaret Hospital experience. Int J Radiat Oncol Biol Phys 1984, 10, 489-497.
45. Carde P, Burgers JM, van Glabbeke M, Hayat M, Cosset JM, Somers R. Combined radiotherapy-chemotherapy for early stages non-Hodgkin's lymphoma, the 1975-1980 EORTC controlled lymphoma trial. Radiother Oncol 1984, 2, 301-312.
46. Sutcliffe SB, Gospodarowicz MK, Bush RS, et al. Role of radiation therapy in non-Hodgkin's lymphoma. Radiother Oncol 1985, 4, 211-223.
47. Hoppe RT. The role of radiation therapy in the management of the non-Hodgkin's lymphomas. Cancer 1985, 55, 2176-2183.
48. Tubiana M, Carde P, Burgers JM, Cosset JM, van Glabbeke M, Somers R. Prognostic factors in non-Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys 1986, 12, 503-514.
49. Phillips DL. Radiotherapy in the treatment of localised non-Hodgkin's lymphoma (Report No. 16). Clin Radiol 1981, 32, 543-546.
50. Rosenberg SA, Berard CW, Brown BW, et al. Study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. Cancer 1982, 49, 2112-2135.
51. Boag JW. Maximum likelihood estimates of the proportion of patients cured by cancer therapy. J R Stat Soc 1949, 11, 15-53.
52. Gamel JW, McLean IW, Rosenberg SA. Proportion cured and mean log survival time as functions of tumour size. Stat Med 1990, 9, 999-1006.
53. Gordon NH. Application of the theory of finite mixtures for the estimation of 'cure' rates of treated cancer patients. Stat Med 1990, 9, 397-407.
54. Kaplan EL, Meier P. Non-parametric estimation from incomplete observation. J Am Stat Assoc 1958, 53, 457-481.
55. Peto R, Pike MC, Armitage P, et al. Design and analysis of randomised clinical trials requiring prolonged observations of each patient. II. Analysis and examples. Br J Cancer 1977, 35, 1-39.
56. Cox DR. Regression models and life tables. J R Stat Soc 1972, 34, 187-220.
57. Jones SE, Fuks Z, Bull M, et al. Non-Hodgkin's lymphomas: IV. Clinicopathologic correlation in 405 cases. Cancer 1973, 31, 806-823.
58. Ciampi A, Bush RS, Gospodarowicz M, Till J. An approach to classifying prognostic factors related to survival experience for non-Hodgkin's lymphoma patients. Cancer 1981, 47, 621-627.
59. Straus DJ, Gaynor JJ, Leiberman PH, Filippa DA, Koziner B, Clarkson BD. Non-Hodgkin's lymphomas: characteristics of long-term survivors following conservative treatment. Am J Med 1987, 82, 247-256.
60. Bonnadonna G, Saccani-Jotti G. Prognostic factors and response to treatment in non-Hodgkin's lymphoma. Anticancer Res 1987, 7, 685-694.
61. Ngan BY, Chen-Levy Z, Weiss LM, Warnke R, Cleary ML. Expression in non-Hodgkin's lymphoma of the BCL-2 protein associated with the T(14,18) chromosomal translocation. N Engl J Med 1988, 318, 1638-1644.